Please assess the completion status of the following clinical trial:

Trial Title: Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with symptomatic FAI~* Clinical and radiographic evidence of FAI~* Patients able to provide consent to study participation~* Completion of 6 weeks of physical therapy program~Exclusion Criteria:~* Established Osteoarthritis (Kellgren-Lawrence \> 3)~* Minimum joint space \> 2 mm as measured on AP radiograph~* Hip dysplasia (center edge angle \< 20° on AP radiograph)~* Patients with clinically significant cardiovascular, renal, hepatic, endocrine disease, cancer or diabetes~* Patients with ongoing infection including HIV and Hepatitis~* Patient with history of osteomyelitis/septic arthritis~* Anticoagulation therapy~* Patients who are pregnant or breast feeding~* Patients with systemic, rheumatic or inflammatory disease of the knee or chondrocalcinosis, hemochromatosis, inflammatory arthritis, arthropathy of the knee associated with juxta-articular Paget's disease of the femur or tibia, hemophilic arthropathy, infectious arthritis, Charcot's knee joint, villonodular synovitis, and synovial chondromatosis~* Patients taking immunosuppressant medication~* Patients with abnormal hematology or serum chemistry lab results~* Patients receiving injection to treatment knee within 2 months of study enrollment~* BMI greater than 35 or less than 20

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- platelet-rich plasma (Type: EXPERIMENTAL): platelet-rich plasma injection into the head-neck junction of the hip joint
- Kenalog 10 mg/mL Injectable Suspension (Type: ACTIVE_COMPARATOR): corticosteroid injection into the head-neck junction of the hip joint

Based on this trial design, predict the completion outcome and termination type (if applicable).